The New Architecture for Therapeutics
NEWS

Updates on Circurna’s platform, programs, and partnerships

This page provides updates on Circurna’s scientific progress, strategic partnerships, funding support, and participation in industry and scientific forums. Content is intended to share factual company milestones and external validation of our ciRNA™ platform.
Vector
Vector
Circurna Co-Founder Dr. Mariano A. Garcia-Blanco Elected President of the RNA Society
Read more
GMP Circular RNA LNP – Process Development and Manufacturing Innovations for the Next Frontier of ATMPs
Webinar: GMP Circular RNA LNP – Process Development and Manufacturing Innovations for the Next Frontier of ATMPs
Read more
Circurna to Participate in Four Leading RNA and Oncology Conferences in 2026
Read more
Circurna Appoints Robert Rickert, Ph.D., as Chief Scientific Officer
Read more
Circurna partnership.
uBriGene–Circurna Partnership Accelerates Circular RNA/LNP Therapeutics
Read more
A graphic for "Circurna" showing a blue, textured circular RNA structure.
What is Circular RNA and Why Does It Matter?
Read more
Load More
Left Gradient
Right Color Gradient

Stay Connected

Receive updates on Circurna’s scientific progress, partnerships, and key milestones.

Join our mailing list or contact the company directly for inquiries related to partnerships or investor relations.

Vector